17. Multiple system atrophy Clinical trials / Disease details

Clinical trials : 118 / Drugs : 163 - (DrugBank : 49) / Drug target genes : 61 - Drug target pathways : 112

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02726711 (ClinicalTrials.gov)	April 2016	28/1/2016	Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic	Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2	Multiple System Atrophy;Orthostatic Hypotension;Supine Hypertension	Drug: Trimethaphan;Drug: Placebo	Vanderbilt University	NULL	Active, not recruiting	40 Years	80 Years	All	2	Phase 1	United States
2	NCT00179023 (ClinicalTrials.gov)	April 2003	13/9/2005	The Autonomic Nervous System and Obesity	The Autonomic Nervous System and Obesity	OBESITY;HYPERTENSION;PURE AUTONOMIC FAILURE;SHY-DRAGER SYNDROME	Drug: Trimethaphan;Drug: Pseudoephedrine	Vanderbilt University	NULL	Completed	18 Years	80 Years	All	128	Phase 1	United States